首页 > 最新文献

Reproductive biomedicine online最新文献

英文 中文
Comparative Molecular Profiling of Exosomes from First-Trimester Human Placental Organoids and Explants 孕早期人类胎盘类器官和外植体外泌体的比较分子谱分析
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rbmo.2025.105318
Kerem Dalgic , Melike Ucak , Arda Inanc , Gizem Melis Kargin , Mert Turgal , Ozgur Oktem , Bora Akgun , Ciler Celik Ozenci

OBJECTIVE

Exosomes are extracellular vesicles critical for intercellular communication, particularly in maternal–fetal signaling. This study aimed to isolate and characterize exosomes from human placenta organoids (HPOs) and compare their molecular profiles to those of exosomes from first-trimester placental explants.

MATERIALS AND METHODS

First-trimester placenta tissues (6–9 weeks; n = 9) were collected with informed consent (Ethics No:2025.107.IRB2.052). Villous explants were cultured at 24/48h in DMEM/F12+10% exosome-free FBS+1% penicillin-streptomycin, while HPOs were formed via cytotrophoblast cells embedded in Matrigel and maintained in trophoblast organoid medium (TOM). Explants were immunostained for CK7, Ki67, β-hCG, and vimentin; HPOs were evaluated via immunofluorescence (CK7, TP63, β-hCG, Ki67, E-cadherin), and β-hCG secretion was measured by ELISA. Conditioned media from explants and HPOs (day 3/8) were collected for exosome isolation by ultracentrifugation (100,000 × g, 2h, 4°C). Exosomes were analyzed by NTA, TEM, Western blot [CD63 (general), PLAP (placenta-specific), β-actin (negative) exosome markers], and RT-qPCR (miR-517a-3p, miR-519d-3p). PLAP expression in exosomes from term explants served as a positive control. Molecular fingerprints were assessed by surface-enhanced Raman spectroscopy (SERS). Statistical analysis included Mann-Whitney U test with Bonferroni correction for SERS data (p< 0.001) and Kruskal-Wallis test for non-parametric NTA results (p< 0.05).

RESULTS

Exosomes from both groups displayed characteristic morphology, marker expression, and size range (30–150 nm). Explant-derived exosomes had significantly higher particle concentrations (9.33 × 10¹⁰±8.71 × 10⁹ at 24h; 9.04 × 10¹⁰±6.72 × 10⁹ at 48h) than HPO-derived exosomes (3.19 × 10¹⁰±1.60 × 10⁹ at day 3; 3.71 × 10¹⁰±2.64 × 10⁹ at day 8) (p< 0.05). CD63 was detected in exosomes for both groups; PLAP and β-actin were absent. TEM confirmed typical exosome morphology. Placenta-specific miRNAs were expressed in both groups. SERS revealed significant spectral differences (p< 0.001) at 1080, 1445, and 1508 cm⁻¹, indicating differences in lipid and protein composition.

CONCLUSIONS

HPO-derived exosomes share key features with exosomes from matched first-trimester placenta explants, supporting the utility of HPOs as a relevant in vitro model to study placental extracellular vesicles.

IMPACT STATEMENT

This study introduces HPOs as a scalable source for placenta exosome research, enabling investigation of maternal–fetal signaling and pregnancy-related disorders.
目的外泌体是细胞外囊泡,对细胞间通讯至关重要,特别是在母胎信号传导中。本研究旨在分离和表征人胎盘类器官(HPOs)的外泌体,并将其与妊娠早期胎盘外植体的外泌体进行比较。材料与方法收集妊娠早期胎盘组织(6-9周;n = 9),并征得知情同意(伦理号:2025.107.IRB2.052)。绒毛外植体在DMEM/F12+10%不含外泌体的FBS+1%青霉素-链霉素培养基中培养24/48h, HPOs由细胞滋养层细胞包埋在Matrigel中形成,并在滋养层类器官培养基(TOM)中维持。对外植体进行CK7、Ki67、β-hCG和vimentin的免疫染色;免疫荧光法检测HPOs (CK7、TP63、β-hCG、Ki67、E-cadherin), ELISA法检测β-hCG分泌。从外植体和HPOs中收集条件培养基(第3/8天),通过超离心(100,000 × g, 2h, 4°C)分离外泌体。外泌体采用NTA、TEM、Western blot [CD63(一般)、PLAP(胎盘特异性)、β-肌动蛋白(阴性)外泌体标记物]和RT-qPCR (miR-517a-3p、miR-519d-3p)分析。PLAP在外植体中的表达作为阳性对照。采用表面增强拉曼光谱(SERS)评价分子指纹图谱。统计分析采用Mann-Whitney U检验对SERS数据进行Bonferroni校正(p< 0.001),对非参数NTA结果进行Kruskal-Wallis检验(p< 0.05)。结果两组的染色体形态、标记表达和大小范围(30-150 nm)均具有特异性。Explant-derived液有显著较高的粒子浓度(9.33 ×10 ¹⁰ ±8.71×10 ⁹24小时;9.04 ×10 ¹⁰ ±6.72×10 ⁹48 h)比HPO-derived液(3.19 ×10 ¹⁰ ±1.60×10 ⁹第三天,3.71 ×10 ¹⁰ ±2.64×10 ⁹第8天)(术中; 0.05)。两组外泌体均检测到CD63;PLAP和β-肌动蛋白缺失。透射电镜证实了典型的外泌体形态。两组均表达胎盘特异性mirna。SERS在1080、1445和1508 cm( - 1)处显示了显著的光谱差异(p<; 0.001),表明了脂质和蛋白质组成的差异。结论shpo衍生的外泌体与来自匹配的妊娠早期胎盘外植体的外泌体具有相同的关键特征,支持hpo作为研究胎盘细胞外囊泡的相关体外模型的实用性。影响声明:本研究将HPOs作为胎盘外泌体研究的可扩展来源,使母胎信号传导和妊娠相关疾病的研究成为可能。
{"title":"Comparative Molecular Profiling of Exosomes from First-Trimester Human Placental Organoids and Explants","authors":"Kerem Dalgic ,&nbsp;Melike Ucak ,&nbsp;Arda Inanc ,&nbsp;Gizem Melis Kargin ,&nbsp;Mert Turgal ,&nbsp;Ozgur Oktem ,&nbsp;Bora Akgun ,&nbsp;Ciler Celik Ozenci","doi":"10.1016/j.rbmo.2025.105318","DOIUrl":"10.1016/j.rbmo.2025.105318","url":null,"abstract":"<div><h3>OBJECTIVE</h3><div>Exosomes are extracellular vesicles critical for intercellular communication, particularly in maternal–fetal signaling. This study aimed to isolate and characterize exosomes from human placenta organoids (HPOs) and compare their molecular profiles to those of exosomes from first-trimester placental explants.</div></div><div><h3>MATERIALS AND METHODS</h3><div>First-trimester placenta tissues (6–9 weeks; n = 9) were collected with informed consent (Ethics No:2025.107.IRB2.052). Villous explants were cultured at 24/48h in DMEM/F12+10% exosome-free FBS+1% penicillin-streptomycin, while HPOs were formed via cytotrophoblast cells embedded in Matrigel and maintained in trophoblast organoid medium (TOM). Explants were immunostained for CK7, Ki67, β-hCG, and vimentin; HPOs were evaluated via immunofluorescence (CK7, TP63, β-hCG, Ki67, E-cadherin), and β-hCG secretion was measured by ELISA. Conditioned media from explants and HPOs (day 3/8) were collected for exosome isolation by ultracentrifugation (100,000 × g, 2h, 4°C). Exosomes were analyzed by NTA, TEM, Western blot [CD63 (general), PLAP (placenta-specific), β-actin (negative) exosome markers], and RT-qPCR (miR-517a-3p, miR-519d-3p). PLAP expression in exosomes from term explants served as a positive control. Molecular fingerprints were assessed by surface-enhanced Raman spectroscopy (SERS). Statistical analysis included Mann-Whitney U test with Bonferroni correction for SERS data (p&lt; 0.001) and Kruskal-Wallis test for non-parametric NTA results (p&lt; 0.05).</div></div><div><h3>RESULTS</h3><div>Exosomes from both groups displayed characteristic morphology, marker expression, and size range (30–150 nm). Explant-derived exosomes had significantly higher particle concentrations (9.33 × 10¹⁰±8.71 × 10⁹ at 24h; 9.04 × 10¹⁰±6.72 × 10⁹ at 48h) than HPO-derived exosomes (3.19 × 10¹⁰±1.60 × 10⁹ at day 3; 3.71 × 10¹⁰±2.64 × 10⁹ at day 8) (p&lt; 0.05). CD63 was detected in exosomes for both groups; PLAP and β-actin were absent. TEM confirmed typical exosome morphology. Placenta-specific miRNAs were expressed in both groups. SERS revealed significant spectral differences (p&lt; 0.001) at 1080, 1445, and 1508 cm⁻¹, indicating differences in lipid and protein composition.</div></div><div><h3>CONCLUSIONS</h3><div>HPO-derived exosomes share key features with exosomes from matched first-trimester placenta explants, supporting the utility of HPOs as a relevant in vitro model to study placental extracellular vesicles.</div></div><div><h3>IMPACT STATEMENT</h3><div>This study introduces HPOs as a scalable source for placenta exosome research, enabling investigation of maternal–fetal signaling and pregnancy-related disorders.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"51 ","pages":"Article 105318"},"PeriodicalIF":3.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145532784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Loss of Per1 and Per2 Leads to Postnatal Growth Impairment Mimicking Fetal Growth Restriction Per1和Per2的缺失导致类似胎儿生长限制的出生后生长障碍
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rbmo.2025.105319
Begum Durkut Kuzu , Yaren Sevval Yilmaz , Cagla Faki , Hana Asghari , Derya Deniz Ozdemir , Ciler Celik Ozenci

OBJECTIVE

Circadian disruption during pregnancy is clinically associated with an increased risk of fetal growth restriction; however, the underlying mechanisms remain largely unknown. To investigate the role of core circadian genes Per1 and Per2 in developmental growth, we analyzed early postnatal outcomes in a double knockout (dKO) mouse model.

MATERIALS AND METHODS

Per1/Per2 dKO mouse lines were generated on a CB6F1 background using CRISPR/Cas9 genome editing, with ethical approval obtained from the institutional committee (2023.HADYEK.005). Genotyping was performed by agarose gel electrophoresis and validated through Sanger sequencing. Two experimental groups were established based on genotype: heterozygous Per1+/–/Per2+/– (dKO-het) and homozygous Per1–/–/Per2–/– (dKO-hom) breeding pairs. Gestational duration, pup number, pup body weight, and crown–rump length were recorded on postnatal days 7, 14, and 21. Data were shown as mean ± SD at each time point.

RESULTS

Mutant lines carried a nucleotide substitution and deletion in exon 2 of Per1, and a 19-bp deletion in exon 4 of Per2. Gestational duration was consistently 19 days across groups, and litter size was comparable between heterozygous (n=4) and homozygous dKO (n=2) breeders (6.75 ± 0.96 vs. 5.00 ± 2.83 pups per litter). However, dKO-hom pups (n=8) exhibited lower body weights compared to dKO-het pups (n=10): day 7, 4.02 ± 0.57 g vs. 4.77 ± 0.56 g (16% decrease); day 14, 6.16 ± 0.72 g vs. 8.43 ± 0.23 g (27% decrease); and day 21, 8.31 ± 0.89 g vs. 9.77 ± 0.84 g (15% decrease). Similarly, crown–rump lengths were reduced in homozygous dKO pups: day 7, 4.26 ± 0.21 cm vs. 4.37 ± 0.23 cm (3% decrease); day 14, 5.33 ± 0.22 cm vs. 6.00 ± 0.19 cm (12% decrease); and day 21, 6.05 ± 0.29 cm vs. 6.13 ± 0.27 cm (2% decrease).

CONCLUSIONS

We demonstrate that Per1/Per2 deficiency leads to postnatal growth impairment, despite normal gestational duration and litter size, recapitulating features of fetal growth restriction. This model provides a valuable tool for investigating the molecular mechanisms linking circadian clock disruption to developmental growth deficits.

IMPACT STATEMENT

This study establishes a novel genetic model linking core circadian clock gene disruption to postnatal growth impairment, providing key mechanistic insight into how parental circadian disruption may contribute to fetal growth restriction. The Per1/Per2 double knockout mouse offers a valuable platform for investigating circadian-regulated pathways in developmental biology.
目的:妊娠期昼夜节律紊乱与胎儿生长受限风险增加有临床相关性;然而,潜在的机制在很大程度上仍然未知。为了研究核心昼夜节律基因Per1和Per2在发育生长中的作用,我们分析了双敲除(dKO)小鼠模型的早期产后结局。材料与方法使用CRISPR/Cas9基因组编辑技术在CB6F1背景下生成sper1 /Per2 dKO小鼠系,并获得机构委员会(2023.HADYEK.005)的伦理批准。琼脂糖凝胶电泳进行基因分型,Sanger测序验证。按基因型分别设置Per1+/ - /Per2+/ - (dKO-het)杂合组和Per1 - / - /Per2 - / - (dko - homm)纯合组。在出生后第7、14和21天分别记录妊娠期、幼犬数、幼犬体重和冠臀长。每个时间点的数据以mean±SD表示。结果突变株在Per1的外显子2上携带核苷酸替换和缺失,在Per2的外显子4上携带一个19 bp的缺失。各组妊娠期均为19 d,杂合子(n=4)和纯合子dKO (n=2)的产仔数相当(每窝6.75只 ± 0.96只vs. 5.00只 ± 2.83只)。然而,与dko -热幼崽(n=10)相比,dko -热幼崽(n=8)表现出较低的体重:第7天,4.02 ± 0.57 g vs. 4.77 ± 0.56 g(减少16%); 14天,6.16±0.72  g和8.43 ±0.23  g(下降27%);0.89和8.31天21日 ±  g和9.77 ±0.84  g(下降15%)。同样,纯合子dKO幼崽的冠臀长度也减少了:第7天,4.26 ± 0.21 cm vs. 4.37 ± 0.23 cm(减少3%);第14天,5.33 ±  0.22厘米和6.00 ±0.19  厘米(下降12%);和21天,6.05 ±  0.29厘米和6.13 ±0.27  厘米(下降2%)。结论:尽管妊娠期和产仔数正常,但Per1/Per2缺乏会导致出生后生长障碍,重现胎儿生长受限的特征。该模型为研究生物钟紊乱与发育生长缺陷之间的分子机制提供了有价值的工具。影响声明本研究建立了一个新的遗传模型,将核心生物钟基因破坏与出生后生长障碍联系起来,为父母昼夜节律破坏如何导致胎儿生长限制提供了关键的机制见解。Per1/Per2双敲除小鼠为研究发育生物学中昼夜调节途径提供了一个有价值的平台。
{"title":"Loss of Per1 and Per2 Leads to Postnatal Growth Impairment Mimicking Fetal Growth Restriction","authors":"Begum Durkut Kuzu ,&nbsp;Yaren Sevval Yilmaz ,&nbsp;Cagla Faki ,&nbsp;Hana Asghari ,&nbsp;Derya Deniz Ozdemir ,&nbsp;Ciler Celik Ozenci","doi":"10.1016/j.rbmo.2025.105319","DOIUrl":"10.1016/j.rbmo.2025.105319","url":null,"abstract":"<div><h3>OBJECTIVE</h3><div>Circadian disruption during pregnancy is clinically associated with an increased risk of fetal growth restriction; however, the underlying mechanisms remain largely unknown. To investigate the role of core circadian genes Per1 and Per2 in developmental growth, we analyzed early postnatal outcomes in a double knockout (dKO) mouse model.</div></div><div><h3>MATERIALS AND METHODS</h3><div>Per1/Per2 dKO mouse lines were generated on a CB6F1 background using CRISPR/Cas9 genome editing, with ethical approval obtained from the institutional committee (2023.HADYEK.005). Genotyping was performed by agarose gel electrophoresis and validated through Sanger sequencing. Two experimental groups were established based on genotype: heterozygous Per1+/–/Per2+/– (dKO-het) and homozygous Per1–/–/Per2–/– (dKO-hom) breeding pairs. Gestational duration, pup number, pup body weight, and crown–rump length were recorded on postnatal days 7, 14, and 21. Data were shown as mean ± SD at each time point.</div></div><div><h3>RESULTS</h3><div>Mutant lines carried a nucleotide substitution and deletion in exon 2 of Per1, and a 19-bp deletion in exon 4 of Per2. Gestational duration was consistently 19 days across groups, and litter size was comparable between heterozygous (n=4) and homozygous dKO (n=2) breeders (6.75 ± 0.96 vs. 5.00 ± 2.83 pups per litter). However, dKO-hom pups (n=8) exhibited lower body weights compared to dKO-het pups (n=10): day 7, 4.02 ± 0.57 g vs. 4.77 ± 0.56 g (16% decrease); day 14, 6.16 ± 0.72 g vs. 8.43 ± 0.23 g (27% decrease); and day 21, 8.31 ± 0.89 g vs. 9.77 ± 0.84 g (15% decrease). Similarly, crown–rump lengths were reduced in homozygous dKO pups: day 7, 4.26 ± 0.21 cm vs. 4.37 ± 0.23 cm (3% decrease); day 14, 5.33 ± 0.22 cm vs. 6.00 ± 0.19 cm (12% decrease); and day 21, 6.05 ± 0.29 cm vs. 6.13 ± 0.27 cm (2% decrease).</div></div><div><h3>CONCLUSIONS</h3><div>We demonstrate that Per1/Per2 deficiency leads to postnatal growth impairment, despite normal gestational duration and litter size, recapitulating features of fetal growth restriction. This model provides a valuable tool for investigating the molecular mechanisms linking circadian clock disruption to developmental growth deficits.</div></div><div><h3>IMPACT STATEMENT</h3><div>This study establishes a novel genetic model linking core circadian clock gene disruption to postnatal growth impairment, providing key mechanistic insight into how parental circadian disruption may contribute to fetal growth restriction. The Per1/Per2 double knockout mouse offers a valuable platform for investigating circadian-regulated pathways in developmental biology.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"51 ","pages":"Article 105319"},"PeriodicalIF":3.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145532785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low Oxygen Promotes Energy-Efficient Metabolism in Cumulus-Oocyte Complexes During IVM 低氧促进IVM过程中卵丘-卵母细胞复合物的高能效代谢
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rbmo.2025.105291
Ellen Anckaert , Gamze Ates , Heidi Van Ranst , Linde Mostinckx , Wilfried Cools , Ann Massie , Michel De Vos , Nazli Akin

OBJECTIVE

In vitro maturation (IVM) is a mild-approach assisted reproductive technology designed to obtain mature oocytes after culturing cumulus–oocyte complexes (COCs) from 2–10 mm antral follicles. Particularly recommended for women with polycystic ovarian syndrome, IVM eliminates the risk of ovarian hyperstimulation with minimal or no gonadotropin use and abandoned ovulation trigger. Biphasic IVM culture systems are the most effective protocols with a pre-IVM phase supporting cytoplasmic maturation and oocyte competence under meiotic arrest, followed by IVM for nuclear maturation. There is currently no consensus on IVM culture oxygen settings: while in vivo COCs are exposed to low oxygen (2–9%), IVM is typically performed at atmospheric oxygen. Here we assess the effects of environmental conditions on COC energy metabolism performing pre-IVM under physiological (5%) vs atmospheric (20%) O₂.

MATERIALS AND METHODS

Hyperresponder (non-PCOS) research oocyte donors (n=21) received minimal stimulation (75-150 IU menopur/day) for 0-2 days to collect COCs (n = 221) from follicles <10 mm. After oocyte pick-up, COCs were randomly allocated to both atmospheric and physiological O2, for pre-IVM culture (22h). At the end of the culture, the COCs were processed to assess real-time metabolism, measure ATP concentrations, evaluate mitochondrial and antioxidative functions (CellROX, JC-1, and mBCl staining). Spent medium was analyzed for glucose and lactate. Statistical analysis was completed with a t-test or linear mixed model test.

RESULTS

A greater proportion of ATP was produced via mitochondrial respiration at 20% O₂ compared to 5% O₂ (43±5% vs 27±10%, p<0.05). Yet, overall ATP production was greater in COCs cultured under 5% O₂ (50.3 ± 17.9 nmol/μg vs. 75.2 ± 32.7 nmol/μg, p<0.05). Glucose uptake was similar between conditions, while lactate production was elevated with 5% O₂ (0.04 ± 0.03 mmol/L/COC vs 0.06 ± 0.03 mmol/L/COC, p<0.05). Mitochondrial and antioxidative functions between groups were comparable.

CONCLUSIONS

This exploratory study shows that culturing COCs under 5% O₂ during pre-IVM leads to lower mitochondrial activity. While lacking clinical outcomes, the results support the idea that physiological conditions might be favoring an efficient energy metabolism, compared to metabolic exhaustion, possibly through lipid utilization rather than glucose.

IMPACT STATEMENT

Our results highlight the potential of low O2 levels to improve metabolic efficiency during IVM, encouraging re-evaluation of standard culture conditions.
目的体外成熟(IVM)是一种温和的辅助生殖技术,旨在从2-10 mm的卵泡中培养卵丘-卵母细胞复合物(COCs)获得成熟的卵母细胞。特别推荐用于多囊卵巢综合征的妇女,IVM消除卵巢过度刺激的风险,很少或不使用促性腺激素和放弃排卵触发器。双相IVM培养系统是最有效的方案,其前IVM阶段支持细胞质成熟和卵母细胞在减数分裂停止时的能力,然后IVM用于核成熟。目前对IVM培养的氧环境没有共识:体内COCs暴露于低氧(2-9%),而IVM通常在大气氧下进行。在这里,我们评估了环境条件对在生理(5%)和大气(20%)O₂下进行预ivm的COC能量代谢的影响。材料与方法无反应者(非pcos)研究的卵母细胞供者(n=21)接受最小刺激(75-150 IU /天)0-2天,从10 mm卵泡中收集COCs (n = 221)。提取卵母细胞后,将COCs随机分配到大气和生理O2中进行预ivm培养(22h)。在培养结束时,对COCs进行处理以评估实时代谢,测量ATP浓度,评估线粒体和抗氧化功能(CellROX, JC-1和mBCl染色)。用废培养基分析葡萄糖和乳酸。统计分析采用t检验或线性混合模型检验。结果:与5% O₂相比,20% O₂时线粒体呼吸产生ATP的比例更高(43±5% vs 27±10%,p<0.05)。然而,在5% O₂条件下培养的COCs中,总ATP产量更高(50.3 ± 17.9 nmol/μg vs. 75.2 ± 32.7 nmol/μg, p<0.05)。不同条件下葡萄糖摄取相似,而乳酸产量增加5% O₂(0.04 ± 0.03 mmol/L/COC vs 0.06 ± 0.03 mmol/L/COC, p<0.05)。两组间线粒体和抗氧化功能具有可比性。结论本探索性研究表明,在预ivm期间,在5% O₂下培养COCs可降低线粒体活性。虽然缺乏临床结果,但结果支持这样一种观点,即生理条件可能有利于有效的能量代谢,而不是代谢耗竭,可能是通过脂质利用而不是葡萄糖。影响声明我们的研究结果强调了低氧水平在IVM期间提高代谢效率的潜力,鼓励对标准培养条件进行重新评估。
{"title":"Low Oxygen Promotes Energy-Efficient Metabolism in Cumulus-Oocyte Complexes During IVM","authors":"Ellen Anckaert ,&nbsp;Gamze Ates ,&nbsp;Heidi Van Ranst ,&nbsp;Linde Mostinckx ,&nbsp;Wilfried Cools ,&nbsp;Ann Massie ,&nbsp;Michel De Vos ,&nbsp;Nazli Akin","doi":"10.1016/j.rbmo.2025.105291","DOIUrl":"10.1016/j.rbmo.2025.105291","url":null,"abstract":"<div><h3>OBJECTIVE</h3><div>In vitro maturation (IVM) is a mild-approach assisted reproductive technology designed to obtain mature oocytes after culturing cumulus–oocyte complexes (COCs) from 2–10 mm antral follicles. Particularly recommended for women with polycystic ovarian syndrome, IVM eliminates the risk of ovarian hyperstimulation with minimal or no gonadotropin use and abandoned ovulation trigger. Biphasic IVM culture systems are the most effective protocols with a pre-IVM phase supporting cytoplasmic maturation and oocyte competence under meiotic arrest, followed by IVM for nuclear maturation. There is currently no consensus on IVM culture oxygen settings: while in vivo COCs are exposed to low oxygen (2–9%), IVM is typically performed at atmospheric oxygen. Here we assess the effects of environmental conditions on COC energy metabolism performing pre-IVM under physiological (5%) vs atmospheric (20%) O₂.</div></div><div><h3>MATERIALS AND METHODS</h3><div>Hyperresponder (non-PCOS) research oocyte donors (n=21) received minimal stimulation (75-150 IU menopur/day) for 0-2 days to collect COCs (n = 221) from follicles &lt;10 mm. After oocyte pick-up, COCs were randomly allocated to both atmospheric and physiological O2, for pre-IVM culture (22h). At the end of the culture, the COCs were processed to assess real-time metabolism, measure ATP concentrations, evaluate mitochondrial and antioxidative functions (CellROX, JC-1, and mBCl staining). Spent medium was analyzed for glucose and lactate. Statistical analysis was completed with a t-test or linear mixed model test.</div></div><div><h3>RESULTS</h3><div>A greater proportion of ATP was produced via mitochondrial respiration at 20% O₂ compared to 5% O₂ (43±5% vs 27±10%, p&lt;0.05). Yet, overall ATP production was greater in COCs cultured under 5% O₂ (50.3 ± 17.9 nmol/μg vs. 75.2 ± 32.7 nmol/μg, p&lt;0.05). Glucose uptake was similar between conditions, while lactate production was elevated with 5% O₂ (0.04 ± 0.03 mmol/L/COC vs 0.06 ± 0.03 mmol/L/COC, p&lt;0.05). Mitochondrial and antioxidative functions between groups were comparable.</div></div><div><h3>CONCLUSIONS</h3><div>This exploratory study shows that culturing COCs under 5% O₂ during pre-IVM leads to lower mitochondrial activity. While lacking clinical outcomes, the results support the idea that physiological conditions might be favoring an efficient energy metabolism, compared to metabolic exhaustion, possibly through lipid utilization rather than glucose.</div></div><div><h3>IMPACT STATEMENT</h3><div>Our results highlight the potential of low O2 levels to improve metabolic efficiency during IVM, encouraging re-evaluation of standard culture conditions.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"51 ","pages":"Article 105291"},"PeriodicalIF":3.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145532856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of ICSI-to-Biopsy Inte rval on Embryo Ploidy Status: An Analysis of More Than 9000 Embryos. icsi -活检间隔对胚胎倍性状态的影响:对9000多个胚胎的分析。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rbmo.2025.105292
Meral Gultomruk , Fazilet Kubra Boynukalin , Neslihan Sonmez , Sinan Ozkavukcu , Mustafa Bahceci , Gurkan Bozdag

OBJECTIVE

Fertilized oocytes have the potential to develop into viable blastocysts in vitro by day5(D5), day6(D6), or day7(D7). Blastocyst expansion is key to trophectoderm biopsy (TB) success; biopsy may be ideal when herniation has begun. Due to variability expansion, TB is often delayed until optimal expansion for technical easier. However, data remain inconclusive regarding whether blastocysts with an elongated duration until TB are associated with ploidy status.

MATERIALS AND METHODS

This retrospective cohort study conducted at Bahceci Health Group between January 2020-2024. The study evaluated 9.427 blastocyst stage embryos obtained from 4.616 PGT-A cycle. The interval between ICSI-TB was calculated for each embryo from software records. Time was given as hour: in(h) and minute(min). The interval has been divided into four quartiles separately for D5, and D6 embryos to evaluate the euploidy rates. Aneuploidy rates were compared across the quartiles of time between ICSI-TB. Additionally, logistic regression analysis was performed, incorporating the quartiles separately for D5, and D6 embryos to assess their impact on aneuploidy rates.

RESULTS

A total of 9.427 embryos were evaluated, of which 5.530(58.7%) were D5, and 3.897(41.3%) were D6 blastocyst. Euploidy rates decreased across Q1-Q4 for both D5 embryos 51.1%, 49.9%, 47.4%, 43.4% (p<0.001) and 41.5%, 43.1%, 40.2%, and 33.1% (p<0.001), respectively. Generalize mixed model (GMM) was used to investigate which factors affected the ploidy status of the embryo. GMM revealed that the female age[OR:0.88 CI 95%(0.87-0.89)p<0.001)], embryo quality[ref:good; for poor OR:0.42 CI 95%(0.26-0.67), for moderate OR:0.58 CI 95% (0.51-0.65)p<0.001], and absence of male factor[OR:1.38 CI 95%(1.03-1.84)p=0.029] were the independent determinants for D5 embryos. Female age[OR:0.86 CI 95%(0.85-0.88)p<0.001), embryo quality [ref:good for poor OR:0.33 CI 95%(0.25-0.45), for moderate OR:0.48 CI 95%(0.41-0.56)p<0.001], and ICSI-TB interval Q[ref:Q1, for Q2 OR:1.09 CI 95%(0.89-1.32), for Q3 OR:0.96 CI 95%(0.7-1.17), for Q4 OR:0.75 CI 95%(0.61-0.92)p=0.006] were the independent determinants for D6 embryos.

CONCLUSIONS

The current results suggest that, in D5 blastocysts, a longer duration from ICSI-TB does not predict ploidy status. However, within the D6 blastocyst cohort, embryos in the latest quartile exhibit the worst performance.

IMPACT STATEMENT

A more objective evaluation necessitates precise timing of embryo hatching, which should be assessed using morphokinetic parameters.
目的受精卵母细胞在体外培养第5天(D5)、第6天(D6)或第7天(D7)有可能发育成有活力的囊胚。囊胚扩张是滋养外胚层活检(TB)成功的关键当疝开始时,活检可能是理想的。由于扩展的可变性,结核病往往推迟到技术上最优扩展才进行。然而,关于在结核前持续时间延长的囊胚是否与倍性状态相关的数据仍然没有定论。材料和方法本回顾性队列研究于2020年1月至2024年1月在Bahceci Health Group进行。该研究评估了从4.616个PGT-A周期获得的9.427个囊胚期胚胎。根据软件记录计算每个胚胎的ICSI-TB间隔。时间以小时(h)和分钟(min)表示。D5和D6胚胎的整倍体率分别被划分为4个四分位数。非整倍体率在ICSI-TB之间的四分位数时间进行比较。此外,进行逻辑回归分析,分别纳入D5和D6胚胎的四分位数,以评估其对非整倍体率的影响。结果共检测胚胎9.427个,其中D5囊胚5.530个(58.7%),D6囊胚3.897个(41.3%)。D5胚的整倍性在Q1-Q4分别下降了51.1%、49.9%、47.4%、43.4% (p<0.001)和41.5%、43.1%、40.2%和33.1% (p<0.001)。采用广义混合模型(GMM)研究影响胚倍性状态的因素。GMM显示女性年龄[OR:0.88 CI 95%(0.87-0.89)p<0.001)],胚胎质量[ref:good;差OR:0.42 CI 95%(0.26-0.67),中等OR:0.58 CI 95%(0.51-0.65)p<0.001)和缺乏男性因素[OR:1.38 CI 95%(1.03-1.84)p=0.029]是D5胚胎的独立决定因素。女性年龄[OR:0.86 CI 95%(0.85-0.88)p<0.001),胚胎质量[ref:差OR:0.33 CI 95%(0.25-0.45),中等OR:0.48 CI 95%(0.41-0.56)p<;0.001]和ICSI-TB间隔Q[ref:Q1, Q2 OR:1.09 CI 95%(0.89-1.32), Q3 OR:0.96 CI 95%(0.07 -1.17), Q4 OR:0.75 CI 95%(0.61-0.92)p=0.006]是D6胚胎的独立决定因素。结论目前的结果表明,在D5囊胚中,ICSI-TB持续时间较长并不能预测倍性状态。然而,在D6囊胚群中,最后四分位数的胚胎表现最差。影响声明更客观的评价需要精确的胚胎孵化时间,这应该用形态动力学参数来评估。
{"title":"The Effect of ICSI-to-Biopsy Inte rval on Embryo Ploidy Status: An Analysis of More Than 9000 Embryos.","authors":"Meral Gultomruk ,&nbsp;Fazilet Kubra Boynukalin ,&nbsp;Neslihan Sonmez ,&nbsp;Sinan Ozkavukcu ,&nbsp;Mustafa Bahceci ,&nbsp;Gurkan Bozdag","doi":"10.1016/j.rbmo.2025.105292","DOIUrl":"10.1016/j.rbmo.2025.105292","url":null,"abstract":"<div><h3>OBJECTIVE</h3><div>Fertilized oocytes have the potential to develop into viable blastocysts in vitro by day5(D5), day6(D6), or day7(D7). Blastocyst expansion is key to trophectoderm biopsy (TB) success; biopsy may be ideal when herniation has begun. Due to variability expansion, TB is often delayed until optimal expansion for technical easier. However, data remain inconclusive regarding whether blastocysts with an elongated duration until TB are associated with ploidy status.</div></div><div><h3>MATERIALS AND METHODS</h3><div>This retrospective cohort study conducted at Bahceci Health Group between January 2020-2024. The study evaluated 9.427 blastocyst stage embryos obtained from 4.616 PGT-A cycle. The interval between ICSI-TB was calculated for each embryo from software records. Time was given as hour: in(h) and minute(min). The interval has been divided into four quartiles separately for D5, and D6 embryos to evaluate the euploidy rates. Aneuploidy rates were compared across the quartiles of time between ICSI-TB. Additionally, logistic regression analysis was performed, incorporating the quartiles separately for D5, and D6 embryos to assess their impact on aneuploidy rates.</div></div><div><h3>RESULTS</h3><div>A total of 9.427 embryos were evaluated, of which 5.530(58.7%) were D5, and 3.897(41.3%) were D6 blastocyst. Euploidy rates decreased across Q1-Q4 for both D5 embryos 51.1%, 49.9%, 47.4%, 43.4% (p&lt;0.001) and 41.5%, 43.1%, 40.2%, and 33.1% (p&lt;0.001), respectively. Generalize mixed model (GMM) was used to investigate which factors affected the ploidy status of the embryo. GMM revealed that the female age[OR:0.88 CI 95%(0.87-0.89)p&lt;0.001)], embryo quality[ref:good; for poor OR:0.42 CI 95%(0.26-0.67), for moderate OR:0.58 CI 95% (0.51-0.65)p&lt;0.001], and absence of male factor[OR:1.38 CI 95%(1.03-1.84)p=0.029] were the independent determinants for D5 embryos. Female age[OR:0.86 CI 95%(0.85-0.88)p&lt;0.001), embryo quality [ref:good for poor OR:0.33 CI 95%(0.25-0.45), for moderate OR:0.48 CI 95%(0.41-0.56)p&lt;0.001], and ICSI-TB interval Q[ref:Q1, for Q2 OR:1.09 CI 95%(0.89-1.32), for Q3 OR:0.96 CI 95%(0.7-1.17), for Q4 OR:0.75 CI 95%(0.61-0.92)p=0.006] were the independent determinants for D6 embryos.</div></div><div><h3>CONCLUSIONS</h3><div>The current results suggest that, in D5 blastocysts, a longer duration from ICSI-TB does not predict ploidy status. However, within the D6 blastocyst cohort, embryos in the latest quartile exhibit the worst performance.</div></div><div><h3>IMPACT STATEMENT</h3><div>A more objective evaluation necessitates precise timing of embryo hatching, which should be assessed using morphokinetic parameters.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"51 ","pages":"Article 105292"},"PeriodicalIF":3.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145532858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Homozygous c.838T>C (p.Cys280Arg) Mutation in the ZP1 (Zona Pellucida Glycoprotein 1) Gene in a Patient with EFS 一种新的透明带糖蛋白1 (ZP1)基因纯合子突变
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rbmo.2025.105300
Hande Nalan Tore , Hasan Bulut , Rovshan Jabbarov , Murat Berkkanoglu , Kemal Ozgur , Kevin Coetzee , Tarkan Kalkan

OBJECTIVE

To present a rare case of "true" Empty Follicle Syndrome (EFS) associated with a novel homozygous ZP1 gene mutation and to emphasize the importance of comprehensive genetic analysis in elucidating the aetiology and guiding individualized management in cases of unexplained EFS.

MATERIALS AND METHODS

The case is that of a 33-year-old Asian patient who presented with a 7-year history of primary infertility, with a karyotype of 46, XX,1qh+, which was considered a clinically insignificant variant. The patient’s partner presented with a normal semen analysis and a normal karyotype (46, XY). The patient’s hormone assessment on cycle day 2 of OS showed normal basal E2 (58 pg/m) and LH (0.33 IU/L) levels, and, therefore, she underwent a routine GnRH antagonist OS, starting with a daily 375 IU dose of FSH (225 IU recombinant FSH + 150 IU HMG). When leading follicles reached ∼14 mm, the antagonist was added, with FSH stimulation continuing for 11 days. A Dual trigger (0.2mg GnRH agonist plus 250 ug hCG) was administered on day 12 when leading follicles were >17 mm. Follicles were collected 36 hours after trigger injection. A comprehensive genetic evaluation (LHCGR, ZP1, ZP2, ZP3, FSHR, GDF9, BMP15, PANX1) was performed using whole-exome sequencing (WES) and targeted next-generation sequencing (NGS).

RESULTS

At oocyte pickup (OPU), approximately 35 intact follicles were aspirated; however, no oocytes or cumulus complexes were identified despite thorough microscopic examination. Genetic analysis revealed a homozygous ZP1 c.838T>C (p.Cys280Arg) mutation, classified as likely pathogenic by ACMG. This variant is predicted to impair disulfide bond formation in the zona pellucida, potentially disrupting oocyte release.

CONCLUSIONS

The early use of comprehensive genetic techniques is critical in encountering "true" EFS to guide appropriate treatment planning and set realistic expectations, thereby, enabling a personalized and rational approach to patient management.

IMPACT STATEMENT

This case highlights the critical role of advanced genetic testing in uncovering the underlying aetiology of true Empty Follicle Syndrome (EFS). The identification of a novel homozygous ZP1 mutation not only expands the known genetic spectrum of EFS but also underscores the importance of personalized diagnostic strategies in reproductive medicine. Early genetic evaluation can prevent repeated failed IVF attempts, guide clinical decision-making, and provide meaningful prognostic information for affected patients.
目的报告一例罕见的伴有ZP1基因纯合子突变的“真”空卵泡综合征(EFS),强调综合遗传分析对不明原因的EFS病因分析和指导个体化治疗的重要性。材料与方法该病例为一名33岁的亚洲患者,有7年的原发性不孕症病史,核型为46,XX,1qh+,被认为是临床不显著的变异。患者的伴侣表现出正常的精液分析和正常的核型(46,XY)。患者在OS周期第2天的激素评估显示基础E2 (58 pg/m)和LH (0.33 IU/L)水平正常,因此,她接受了常规GnRH拮抗剂OS,从每天375 IU剂量的FSH (225 IU重组FSH + 150 IU HMG)开始。当前导卵泡达到~ 14 mm时,加入拮抗剂,FSH刺激持续11天。双触发(0.2mg GnRH激动剂加250 ug hCG)在第12天给药,此时先导卵泡为17 mm。触发注射后36小时采集卵泡。采用全外显子组测序(WES)和靶向下一代测序(NGS)对LHCGR、ZP1、ZP2、ZP3、FSHR、GDF9、BMP15、PANX1进行综合遗传评价。结果在卵母细胞采集(OPU)中,抽取了约35个完整卵泡;然而,尽管进行了彻底的显微镜检查,仍未发现卵母细胞或积云复合物。遗传分析显示一个纯合的ZP1 C . 838t >C (p.Cys280Arg)突变,经ACMG分类为可能致病。预计这种变异会损害透明带中二硫键的形成,潜在地破坏卵母细胞的释放。结论早期应用综合遗传技术对发现“真实”的EFS至关重要,可以指导适当的治疗计划和设定切合实际的期望,从而实现个性化和合理的患者管理方法。影响声明:本病例强调了先进的基因检测在揭示真正的空卵泡综合征(EFS)的潜在病因方面的关键作用。新的纯合子ZP1突变的鉴定不仅扩大了已知的EFS遗传谱,而且强调了个性化诊断策略在生殖医学中的重要性。早期基因评估可以预防重复的试管婴儿失败尝试,指导临床决策,并为受影响的患者提供有意义的预后信息。
{"title":"A Novel Homozygous c.838T>C (p.Cys280Arg) Mutation in the ZP1 (Zona Pellucida Glycoprotein 1) Gene in a Patient with EFS","authors":"Hande Nalan Tore ,&nbsp;Hasan Bulut ,&nbsp;Rovshan Jabbarov ,&nbsp;Murat Berkkanoglu ,&nbsp;Kemal Ozgur ,&nbsp;Kevin Coetzee ,&nbsp;Tarkan Kalkan","doi":"10.1016/j.rbmo.2025.105300","DOIUrl":"10.1016/j.rbmo.2025.105300","url":null,"abstract":"<div><h3>OBJECTIVE</h3><div>To present a rare case of \"true\" Empty Follicle Syndrome (EFS) associated with a novel homozygous ZP1 gene mutation and to emphasize the importance of comprehensive genetic analysis in elucidating the aetiology and guiding individualized management in cases of unexplained EFS.</div></div><div><h3>MATERIALS AND METHODS</h3><div>The case is that of a 33-year-old Asian patient who presented with a 7-year history of primary infertility, with a karyotype of 46, XX,1qh+, which was considered a clinically insignificant variant. The patient’s partner presented with a normal semen analysis and a normal karyotype (46, XY). The patient’s hormone assessment on cycle day 2 of OS showed normal basal E2 (58 pg/m) and LH (0.33 IU/L) levels, and, therefore, she underwent a routine GnRH antagonist OS, starting with a daily 375 IU dose of FSH (225 IU recombinant FSH + 150 IU HMG). When leading follicles reached ∼14 mm, the antagonist was added, with FSH stimulation continuing for 11 days. A Dual trigger (0.2mg GnRH agonist plus 250 ug hCG) was administered on day 12 when leading follicles were &gt;17 mm. Follicles were collected 36 hours after trigger injection. A comprehensive genetic evaluation (LHCGR, ZP1, ZP2, ZP3, FSHR, GDF9, BMP15, PANX1) was performed using whole-exome sequencing (WES) and targeted next-generation sequencing (NGS).</div></div><div><h3>RESULTS</h3><div>At oocyte pickup (OPU), approximately 35 intact follicles were aspirated; however, no oocytes or cumulus complexes were identified despite thorough microscopic examination. Genetic analysis revealed a homozygous ZP1 c.838T&gt;C (p.Cys280Arg) mutation, classified as likely pathogenic by ACMG. This variant is predicted to impair disulfide bond formation in the zona pellucida, potentially disrupting oocyte release.</div></div><div><h3>CONCLUSIONS</h3><div>The early use of comprehensive genetic techniques is critical in encountering \"true\" EFS to guide appropriate treatment planning and set realistic expectations, thereby, enabling a personalized and rational approach to patient management.</div></div><div><h3>IMPACT STATEMENT</h3><div>This case highlights the critical role of advanced genetic testing in uncovering the underlying aetiology of true Empty Follicle Syndrome (EFS). The identification of a novel homozygous ZP1 mutation not only expands the known genetic spectrum of EFS but also underscores the importance of personalized diagnostic strategies in reproductive medicine. Early genetic evaluation can prevent repeated failed IVF attempts, guide clinical decision-making, and provide meaningful prognostic information for affected patients.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"51 ","pages":"Article 105300"},"PeriodicalIF":3.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145532399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Too Many Cycles, Limited Capacity: The Impact of Daily Laboratory Workload on Embryological and Clinical Outcomes in ICSI Cycle 过多的周期,有限的能力:每日实验室工作量对ICSI周期胚胎学和临床结果的影响
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rbmo.2025.105296
Havva Yesilleme , Zekiye Gulfem Yurtgezen , Kiper Aslan , Isil Kasapoglu , Gurkan Uncu , Cihan Cakir

OBJECTIVE

With the rising number of patients and increasing procedural complexity in infertility treatment, maintaining an optimal workload balance in embryology laboratories has become essential for achieving successful clinical outcomes. This study aimed to assess whether daily workload, quantified by the number of OPU procedures performed per day, affects embryological and clinical outcomes in ICSI cycles.

MATERIALS AND METHODS

This retrospective study was conducted at the Bursa Uludag University ART Center between 2011 and 2025 and included 4651 ICSI cycles. Cycles involving PGD, fertility preservation, or failed oocyte retrieval were excluded. Based on the number of daily OPU procedures, cycles were categorized into three groups to reflect laboratory workload: Group 1 (1–2 OPUs/day) (n=1870) Group 2 (3–4 OPUs/day) (n=1643), and Group 3 (≥5 OPUs/day) (n=1138). Baseline patient characteristics, hormonal profiles, and ovarian stimulation parameters were compared among groups. Semen parameters and oocyte quality scores were also evaluated. Embryological and clinical outcomes were then analyzed to determine potential associations with workload intensity.

RESULTS

Baseline patient characteristics, hormonal profiles, ovarian stimulation data, sperm parameters, and oocyte quality scores were statistically comparable among the three groups (p > 0.05). While the number of retrieved oocytes and oocyte maturation rates did not differ significantly, both fertilization (p=0.004) and blastulation rates (p=0.046) were negatively correlated with increasing laboratory workload, reaching statistical significance. However, implantation rates following fresh embryo transfers remained similar across all groups (p=0.248).

CONCLUSIONS

The observed decline in fertilization and blastulation rates in association with increased daily laboratory workload highlights a potential vulnerability in embryology practice under high-volume conditions. Nevertheless, the lack of significant difference in implantation rates among fresh transfers suggests that the quality of the resulting blastocyst cohort was sufficient to maintain clinical outcomes in the first transfer.

IMPACT STATEMENT

This study demonstrates that elevated embryology laboratory workload is associated with reduced fertilization and blastulation efficiency, despite stable clinical and laboratory baseline conditions. Optimizing daily case volume and implementing workload management strategies may be essential for sustaining high embryological performance and ensuring consistent ART outcomes.
目的随着不孕症患者数量的增加和治疗程序的复杂性的增加,保持胚胎学实验室的最佳工作量平衡对于取得成功的临床结果至关重要。本研究旨在评估每日工作量(通过每天进行的OPU手术数量来量化)是否影响ICSI周期的胚胎学和临床结果。材料与方法本回顾性研究于2011年至2025年在Bursa Uludag大学艺术中心进行,包括4651个ICSI周期。排除涉及PGD、生育能力保存或卵母细胞回收失败的周期。根据每日OPU程序的数量,将周期分为三组,以反映实验室工作量:第1组(1 - 2 OPU /天)(n=1870),第2组(3 - 4 OPU /天)(n=1643)和第3组(≥5 OPU /天)(n=1138)。比较各组患者的基线特征、激素谱和卵巢刺激参数。精液参数和卵母细胞质量评分也进行了评估。然后分析胚胎学和临床结果,以确定与工作量强度的潜在关联。结果三组患者的基线特征、激素谱、卵巢刺激数据、精子参数和卵母细胞质量评分具有统计学意义(p > 0.05)。虽然取卵数量和卵母细胞成熟率无显著差异,但受精率(p=0.004)和囊胚率(p=0.046)与实验室工作量增加呈负相关,具有统计学意义。然而,新鲜胚胎移植后的着床率在所有组中保持相似(p=0.248)。结论观察到的受精率和囊胚率的下降与日常实验室工作量的增加有关,这表明在高容量条件下胚胎学实践中存在潜在的脆弱性。然而,新鲜移植的着床率没有显著差异,这表明所产生的囊胚队列的质量足以维持第一次移植的临床结果。影响声明本研究表明,尽管临床和实验室基线条件稳定,但胚胎学实验室工作量的增加与受精和囊胚效率的降低有关。优化每日病例量和实施工作量管理策略对于维持高胚胎学表现和确保一致的抗逆转录病毒治疗结果可能至关重要。
{"title":"Too Many Cycles, Limited Capacity: The Impact of Daily Laboratory Workload on Embryological and Clinical Outcomes in ICSI Cycle","authors":"Havva Yesilleme ,&nbsp;Zekiye Gulfem Yurtgezen ,&nbsp;Kiper Aslan ,&nbsp;Isil Kasapoglu ,&nbsp;Gurkan Uncu ,&nbsp;Cihan Cakir","doi":"10.1016/j.rbmo.2025.105296","DOIUrl":"10.1016/j.rbmo.2025.105296","url":null,"abstract":"<div><h3>OBJECTIVE</h3><div>With the rising number of patients and increasing procedural complexity in infertility treatment, maintaining an optimal workload balance in embryology laboratories has become essential for achieving successful clinical outcomes. This study aimed to assess whether daily workload, quantified by the number of OPU procedures performed per day, affects embryological and clinical outcomes in ICSI cycles.</div></div><div><h3>MATERIALS AND METHODS</h3><div>This retrospective study was conducted at the Bursa Uludag University ART Center between 2011 and 2025 and included 4651 ICSI cycles. Cycles involving PGD, fertility preservation, or failed oocyte retrieval were excluded. Based on the number of daily OPU procedures, cycles were categorized into three groups to reflect laboratory workload: Group 1 (1–2 OPUs/day) (n=1870) Group 2 (3–4 OPUs/day) (n=1643), and Group 3 (≥5 OPUs/day) (n=1138). Baseline patient characteristics, hormonal profiles, and ovarian stimulation parameters were compared among groups. Semen parameters and oocyte quality scores were also evaluated. Embryological and clinical outcomes were then analyzed to determine potential associations with workload intensity.</div></div><div><h3>RESULTS</h3><div>Baseline patient characteristics, hormonal profiles, ovarian stimulation data, sperm parameters, and oocyte quality scores were statistically comparable among the three groups (p &gt; 0.05). While the number of retrieved oocytes and oocyte maturation rates did not differ significantly, both fertilization (p=0.004) and blastulation rates (p=0.046) were negatively correlated with increasing laboratory workload, reaching statistical significance. However, implantation rates following fresh embryo transfers remained similar across all groups (p=0.248).</div></div><div><h3>CONCLUSIONS</h3><div>The observed decline in fertilization and blastulation rates in association with increased daily laboratory workload highlights a potential vulnerability in embryology practice under high-volume conditions. Nevertheless, the lack of significant difference in implantation rates among fresh transfers suggests that the quality of the resulting blastocyst cohort was sufficient to maintain clinical outcomes in the first transfer.</div></div><div><h3>IMPACT STATEMENT</h3><div>This study demonstrates that elevated embryology laboratory workload is associated with reduced fertilization and blastulation efficiency, despite stable clinical and laboratory baseline conditions. Optimizing daily case volume and implementing workload management strategies may be essential for sustaining high embryological performance and ensuring consistent ART outcomes.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"51 ","pages":"Article 105296"},"PeriodicalIF":3.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145532478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imatinib Inhibits Proliferation and Migration While Inducing Apoptosis in Endometriotic Cells via c-Abl Pathway Modulation 伊马替尼通过调节c-Abl通路抑制子宫内膜异位症细胞增殖和迁移,同时诱导细胞凋亡
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rbmo.2025.105316
Isil Yenigun , Nazlı Ece Huner , Erkut Attar , Basak Aru , Beyza Gaye Edepli , Elif Kilic , Aylin Yaba

OBJECTIVE

Endometriosis is characterized by the ectopic growth of endometrial tissue, linked to disrupted proliferation and apoptosis. c-Abl (Abelson tyrosine kinase), implicated in these processes, is inhibited by imatinib. However, its role in endometriosis remains unclear. We hypothesized that imatinib may be used as a therapeutic target for endometriosis.

MATERIALS AND METHODS

Endometriotic tissues were collected from patients (n=6, aged 23-45) at Yeditepe University Hospital. Stromal cells were cultured in DMEM/F12 (10% FBS), then treated with 0 (control), 12.5, 25, and 50 µM imatinib for 48 and 72 hours. Proliferation was measured with an automatic cell counter. Apoptosis/viability was assessed via Annexin V/PI staining, and the cell cycle by DNA content analysis. Migration was evaluated by a wound-healing assay. c-Abl and phospho-c-Abl (p-c-Abl) levels were assessed by immunofluorescence.

RESULTS

Proliferation of endometriotic cells significantly decreased at 48 hours with 25 µM and 50 µM imatinib, and at 72 hours in all treatment groups (p<0.01). Early apoptosis was increased in all treatment groups (p<0.05), while late apoptosis was elevated in the 25 µM and 50 µM (p<0.05). Necrotic population was increased in the 12.5 µM and 25 µM groups at 48 hours (p<0.05), and in the 50 µM group at 72 hours (p<0.05). Cell cycle analysis at 48 hours showed G0/G1 arrest with 12.5 μM imatinib (p<0.001), while 50 μM caused cell cycle arrest in S (p<0.05) and G2/M phases (p<0.0001) and promoted aneuploidy. In 72 hours, 12.5 μM imatinib led to G0/G1 arrest (p<0.05), and aneuploidy was observed at 25 and 50 µM imatinib, but cell cycle arrest occurred only at 50 µM, with G2/M arrest (p<0.0001). Cell migration is decreased in all treatment groups(p<0.001). Immunofluorescence in 72 hours showed increased c-Abl at 50µM (p<0.05). In contrast, p-c-Abl levels decreased in all treatment groups (p<0.05).

CONCLUSIONS

Imatinib inhibited proliferation and migration while promoting apoptosis and necrosis in a dose- and time-dependent manner. It alters the cell cycle by causing arrest and may induce aneuploidy. These findings suggest that inhibition of c-Abl activity may play a significant role in endometriotic cell behavior.

IMPACT STATEMENT

The expanding understanding of c-Abl inhibition in endometriosis could provide valuable insights into the underlying mechanisms of endometriosis. We believe that our results may guide future studies on endometriosis and contribute to the development of new therapeutic approaches.
目的子宫内膜异位症的特点是子宫内膜组织异位生长,与增殖和凋亡中断有关。参与这些过程的c-Abl (Abelson酪氨酸激酶)被伊马替尼抑制。然而,其在子宫内膜异位症中的作用尚不清楚。我们假设伊马替尼可以作为子宫内膜异位症的治疗靶点。材料与方法在叶迪特佩大学医院收集6例患者的异位组织(n=6,年龄23-45岁)。基质细胞在DMEM/F12(10%胎牛血清)中培养,然后用0(对照)、12.5、25和50µM伊马替尼处理48和72小时。用自动细胞计数器测量增殖。Annexin V/PI染色检测细胞凋亡/细胞活力,DNA含量分析细胞周期。通过伤口愈合试验评估迁移。免疫荧光法测定c-Abl和磷酸c-Abl (p-c-Abl)水平。结果25µM和50µM伊马替尼治疗后48小时和72小时子宫内膜异位症细胞增殖均显著降低(p < 0.01)。各处理组早期细胞凋亡增加(p < 0.05),晚期细胞凋亡在25µM和50µM时升高(p < 0.05)。12.5µM和25µM组48小时坏死细胞数量增加(p < 0.05), 50µM组72小时坏死细胞数量增加(p < 0.05)。48 h细胞周期分析显示,12.5 μM的伊马替尼阻滞G0/G1期(p<0.001), 50 μM的伊马替尼阻滞S期(p<0.05)和G2/M期(p<0.0001)细胞周期,促进非整倍体。在72小时内,12.5 μM伊马替尼导致G0/G1停止(p<0.05),在25和50µM的伊马替尼下观察到非整倍体,但仅在50µM时发生细胞周期停止,G2/M停止(p<0.0001)。所有治疗组的细胞迁移均减少(p<0.001)。72小时免疫荧光显示50µM时c-Abl升高(p<0.05)。p-c-Abl水平在各治疗组均下降(p < 0.05)。结论西马替尼抑制细胞增殖和迁移,促进细胞凋亡和坏死,具有剂量依赖性和时间依赖性。它通过引起阻滞改变细胞周期,并可能诱发非整倍体。这些发现提示抑制c-Abl活性可能在子宫内膜异位症细胞行为中起重要作用。影响声明对c-Abl抑制在子宫内膜异位症中的作用的进一步了解可以为子宫内膜异位症的潜在机制提供有价值的见解。我们相信我们的结果可以指导未来子宫内膜异位症的研究,并有助于开发新的治疗方法。
{"title":"Imatinib Inhibits Proliferation and Migration While Inducing Apoptosis in Endometriotic Cells via c-Abl Pathway Modulation","authors":"Isil Yenigun ,&nbsp;Nazlı Ece Huner ,&nbsp;Erkut Attar ,&nbsp;Basak Aru ,&nbsp;Beyza Gaye Edepli ,&nbsp;Elif Kilic ,&nbsp;Aylin Yaba","doi":"10.1016/j.rbmo.2025.105316","DOIUrl":"10.1016/j.rbmo.2025.105316","url":null,"abstract":"<div><h3>OBJECTIVE</h3><div>Endometriosis is characterized by the ectopic growth of endometrial tissue, linked to disrupted proliferation and apoptosis. c-Abl (Abelson tyrosine kinase), implicated in these processes, is inhibited by imatinib. However, its role in endometriosis remains unclear. We hypothesized that imatinib may be used as a therapeutic target for endometriosis.</div></div><div><h3>MATERIALS AND METHODS</h3><div>Endometriotic tissues were collected from patients (n=6, aged 23-45) at Yeditepe University Hospital. Stromal cells were cultured in DMEM/F12 (10% FBS), then treated with 0 (control), 12.5, 25, and 50 µM imatinib for 48 and 72 hours. Proliferation was measured with an automatic cell counter. Apoptosis/viability was assessed via Annexin V/PI staining, and the cell cycle by DNA content analysis. Migration was evaluated by a wound-healing assay. c-Abl and phospho-c-Abl (p-c-Abl) levels were assessed by immunofluorescence.</div></div><div><h3>RESULTS</h3><div>Proliferation of endometriotic cells significantly decreased at 48 hours with 25 µM and 50 µM imatinib, and at 72 hours in all treatment groups (p&lt;0.01). Early apoptosis was increased in all treatment groups (p&lt;0.05), while late apoptosis was elevated in the 25 µM and 50 µM (p&lt;0.05). Necrotic population was increased in the 12.5 µM and 25 µM groups at 48 hours (p&lt;0.05), and in the 50 µM group at 72 hours (p&lt;0.05). Cell cycle analysis at 48 hours showed G0/G1 arrest with 12.5 μM imatinib (p&lt;0.001), while 50 μM caused cell cycle arrest in S (p&lt;0.05) and G2/M phases (p&lt;0.0001) and promoted aneuploidy. In 72 hours, 12.5 μM imatinib led to G0/G1 arrest (p&lt;0.05), and aneuploidy was observed at 25 and 50 µM imatinib, but cell cycle arrest occurred only at 50 µM, with G2/M arrest (p&lt;0.0001). Cell migration is decreased in all treatment groups(p&lt;0.001). Immunofluorescence in 72 hours showed increased c-Abl at 50µM (p&lt;0.05). In contrast, p-c-Abl levels decreased in all treatment groups (p&lt;0.05).</div></div><div><h3>CONCLUSIONS</h3><div>Imatinib inhibited proliferation and migration while promoting apoptosis and necrosis in a dose- and time-dependent manner. It alters the cell cycle by causing arrest and may induce aneuploidy. These findings suggest that inhibition of c-Abl activity may play a significant role in endometriotic cell behavior.</div></div><div><h3>IMPACT STATEMENT</h3><div>The expanding understanding of c-Abl inhibition in endometriosis could provide valuable insights into the underlying mechanisms of endometriosis. We believe that our results may guide future studies on endometriosis and contribute to the development of new therapeutic approaches.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"51 ","pages":"Article 105316"},"PeriodicalIF":3.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145532782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is Piezo-Icsi or Calcium Ionofor Superior for Oocyte Activation Compared to Standard Icsi 与标准Icsi相比,压电Icsi或钙离子在卵母细胞激活方面是否更好
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rbmo.2025.105295
Gokalp Oner , Enes Karaman , Ferhan Elmali , Suat Altmisyedioglu , Fatma Ozdemir

OBJECTIVE

Oocyte activation failure is a major cause of embryo arrest, cleavage anomalies, and impaired blastocyst development in assisted reproductive techniques. In intracytoplasmic sperm injection (ICSI) cycles, oocyte activation can be induced using chemical, mechanical, or physical stimuli. Calcium ionophore is the most commonly used chemical agent for artificial activation. PIEZO-ICSI is a mechanical technique that uses a piezoelectric actuator to facilitate precise penetration of the zona pellucida with a microinjection pipette. However, prospective studies directly comparing PIEZO-ICSI and calcium ionophore in patients with prior embryo cleavage arrest are lacking.

MATERIALS AND METHODS

This prospective study included 240 patients with a history of embryo transfer cancellation due to embryo cleavage arrest. Patients with severe male factor infertility, endometriosis, or absolute tubal factor were excluded. Ethical approval was obtained from the Ethics Committee of Nigde Omer Halisdemir University (Approval No: 2025/04-39). Patients were allocated into three groups according to the oocyte activation method used: PIEZO-ICSI, calcium ionophore, or conventional ICSI. The primary outcomes were number of blastocysts, embryo quality, and clinical pregnancy rates.

RESULTS

The groups were similar in age, BMI, antral follicle count, AMH, and baseline hormone levels (FSH, LH, Estradiol). The mean number of retrieved oocytes was comparable across all groups (p = 0.911). PIEZO-ICSI achieved significantly higher fertilization rates (1.69±0.22) compared to conventional ICSI (0.93±0.22; p = 0.045), and also higher pregnancy rates (47% vs. 15%; p < 0.001). Calcium ionophore showed similar fertilization to control (1.51±0.21 vs. 0.93±0.22; p = 0.051), but significantly higher pregnancy rates (40% vs. 15%; p < 0.001). No significant differences were observed between PIEZO-ICSI and calcium ionophore groups.

CONCLUSIONS

Both PIEZO-ICSI and calcium ionophore significantly improved fertilization and pregnancy outcomes in patients with a history of cleavage arrest. This is the first prospective study comparing these two methods. PIEZO-ICSI may serve as a viable mechanical alternative for oocyte activation in selected IVF patients.

IMPACT STATEMENT

PIEZO-ICSI or calcium ionophore may be preferred for oocyte activation in patients with a history of cleavage arrest.
目的:在辅助生殖技术中,卵母细胞激活失败是导致胚胎停滞、卵裂异常和囊胚发育受损的主要原因。在胞浆内单精子注射(ICSI)周期中,卵母细胞的激活可以通过化学、机械或物理刺激来诱导。钙离子载体是人工活化最常用的化学试剂。压电- icsi是一种机械技术,它使用压电致动器来促进微注射移液管精确穿透透明带。然而,直接比较piezoo - icsi和钙离子载体在胚胎卵裂停止患者中的前瞻性研究尚缺乏。材料与方法本前瞻性研究纳入240例因胚胎卵裂停止而取消胚胎移植的患者。严重男性因素不孕、子宫内膜异位症或绝对输卵管因素的患者被排除在外。已获得Nigde Omer Halisdemir大学伦理委员会的伦理批准(批准号:2025/04-39)。根据使用的卵母细胞激活方法,将患者分为三组:piezoo -ICSI,钙离子载体或常规ICSI。主要结果是囊胚数量、胚胎质量和临床妊娠率。结果两组在年龄、BMI、窦卵泡计数、AMH和基线激素水平(FSH、LH、雌二醇)方面相似。所有组的平均卵母细胞数量具有可比性(p = 0.911)。与传统ICSI(0.93±0.22;p = 0.045)相比,PIEZO-ICSI的受精率(1.69±0.22)显著高于传统ICSI(0.93±0.22;p < 0.001),妊娠率也更高(47% vs. 15%; p < 0.001)。钙离子载体的受精率与对照组相似(1.51±0.21∶0.93±0.22;p = 0.051),但妊娠率明显高于对照组(40%∶15%;p < 0.001)。压电- icsi组与钙离子载体组间无显著差异。结论PIEZO-ICSI和钙离子载体均能显著改善乳沟停育史患者的受精和妊娠结局。这是比较这两种方法的首次前瞻性研究。PIEZO-ICSI可以作为一个可行的机械替代卵母细胞激活在选定的试管婴儿患者。影响声明:对于有卵裂停止病史的患者,压电- icsi或钙离子载体可能优先用于卵母细胞激活。
{"title":"Is Piezo-Icsi or Calcium Ionofor Superior for Oocyte Activation Compared to Standard Icsi","authors":"Gokalp Oner ,&nbsp;Enes Karaman ,&nbsp;Ferhan Elmali ,&nbsp;Suat Altmisyedioglu ,&nbsp;Fatma Ozdemir","doi":"10.1016/j.rbmo.2025.105295","DOIUrl":"10.1016/j.rbmo.2025.105295","url":null,"abstract":"<div><h3>OBJECTIVE</h3><div>Oocyte activation failure is a major cause of embryo arrest, cleavage anomalies, and impaired blastocyst development in assisted reproductive techniques. In intracytoplasmic sperm injection (ICSI) cycles, oocyte activation can be induced using chemical, mechanical, or physical stimuli. Calcium ionophore is the most commonly used chemical agent for artificial activation. PIEZO-ICSI is a mechanical technique that uses a piezoelectric actuator to facilitate precise penetration of the zona pellucida with a microinjection pipette. However, prospective studies directly comparing PIEZO-ICSI and calcium ionophore in patients with prior embryo cleavage arrest are lacking.</div></div><div><h3>MATERIALS AND METHODS</h3><div>This prospective study included 240 patients with a history of embryo transfer cancellation due to embryo cleavage arrest. Patients with severe male factor infertility, endometriosis, or absolute tubal factor were excluded. Ethical approval was obtained from the Ethics Committee of Nigde Omer Halisdemir University (Approval No: 2025/04-39). Patients were allocated into three groups according to the oocyte activation method used: PIEZO-ICSI, calcium ionophore, or conventional ICSI. The primary outcomes were number of blastocysts, embryo quality, and clinical pregnancy rates.</div></div><div><h3>RESULTS</h3><div>The groups were similar in age, BMI, antral follicle count, AMH, and baseline hormone levels (FSH, LH, Estradiol). The mean number of retrieved oocytes was comparable across all groups (p = 0.911). PIEZO-ICSI achieved significantly higher fertilization rates (1.69±0.22) compared to conventional ICSI (0.93±0.22; p = 0.045), and also higher pregnancy rates (47% vs. 15%; p &lt; 0.001). Calcium ionophore showed similar fertilization to control (1.51±0.21 vs. 0.93±0.22; p = 0.051), but significantly higher pregnancy rates (40% vs. 15%; p &lt; 0.001). No significant differences were observed between PIEZO-ICSI and calcium ionophore groups.</div></div><div><h3>CONCLUSIONS</h3><div>Both PIEZO-ICSI and calcium ionophore significantly improved fertilization and pregnancy outcomes in patients with a history of cleavage arrest. This is the first prospective study comparing these two methods. PIEZO-ICSI may serve as a viable mechanical alternative for oocyte activation in selected IVF patients.</div></div><div><h3>IMPACT STATEMENT</h3><div>PIEZO-ICSI or calcium ionophore may be preferred for oocyte activation in patients with a history of cleavage arrest.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"51 ","pages":"Article 105295"},"PeriodicalIF":3.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145532862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Clinical and Artificial Intelligence (AI)-Based Interpretation: Agreement and Diagnostic Consistency 临床与人工智能(AI)解释的比较:一致性和诊断一致性
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rbmo.2025.105302
Simge Berrak Beyoglu Oruc , Rozerin Balci , Berfin Baybas , Busra Toper

OBJECTIVE

Artificial intelligence (AI)-based models trained on large datasets and advanced algorithms employ signal processing and pattern recognition techniques to reduce subjectivity and human error in the evaluation of Non-Stress Tests (NST). This study examined the agreement between clinician and AI-based NST evaluations, highlighting AI’s potential in clinical decision support.

MATERIALS AND METHODS

In a cohort of 100 patients, NST parameters were assessed by both clinical interpretation and ChatGPT, categorized into seven subcomponents, and Inter-rater agreement was assessed using Cohen’s Kappa coefficient.

RESULTS

Good agreement was observed between clinician and ChatGPT evaluations (Kappa 0.655, accuracy 77%). Subgroup analyses showed moderate agreement in cases undergoing cesarean section due to fetal distress (Kappa 0.47, accuracy 76%), with ChatGPT classifying 87% of these cases as Category 3. Notably, no patients in this subgroup were classified as Category 1 by ChatGPT, suggesting a conservative approach in high-risk scenarios. In the non-reactive NST subgroup, moderate agreement (0.42) was also observed. In all 9 cases of fetal tachycardia, ChatGPT correctly identified the condition (100% accuracy) and classified 8 of them as Category 2.
When evaluating individual NST parameters, a very strong agreement was observed for the presence of accelerations (0.84). Good agreement was found in NST categorization (0.64), presence of decelerations (0.79),and variability presence (0.67). In contrast, only moderate agreement was observed in the classification of deceleration types (0.53) and grading of variability (0.47) (Table 1). Detailed comparison of deceleration type revealed weak-to-moderate agreement (0.29). “Deep prolonged” decelerations were consistently recognized by both evaluators, whereas significant discrepancies were noted in identifying “recurrent late,” “deep late,” and “variable” patterns. These results indicate that while AI shows acceptable performance in general pattern recognition, its ability to distinguish specific and complex patterns remains limited.

CONCLUSIONS

This study demonstrated moderate agreement between AI and clinical evaluations. The agreement was lower for nuanced parameters, such as deceleration type and variability; yet AI could still support early diagnosis and evidence-based decision-making.

IMPACT STATEMENT

This study introduces an AI-based approach for clinical interpreting, such as NST categorization, aiming to enhance diagnostic clarity and support clinical education.
目的基于人工智能(AI)的模型在大型数据集和高级算法上进行训练,采用信号处理和模式识别技术来减少非压力测试(NST)评估中的主观性和人为错误。本研究考察了临床医生和基于人工智能的NST评估之间的一致性,强调了人工智能在临床决策支持方面的潜力。材料与方法在一组100例患者中,通过临床解释和ChatGPT对NST参数进行评估,将其分为7个子部分,并使用Cohen 's Kappa系数评估评分者间一致性。结果临床与ChatGPT评价结果吻合较好(Kappa 0.655,准确率77%)。亚组分析显示,由于胎儿窘迫而进行剖宫产手术的病例有中等程度的一致性(Kappa 0.47,准确率76%),ChatGPT将87%的病例分类为3类。值得注意的是,该亚组中没有患者被ChatGPT分类为1类,提示在高危情况下采用保守方法。在非反应性NST亚组中,也观察到中度一致性(0.42)。在所有9例胎儿心动过速中,ChatGPT正确识别了病情(100%准确),并将其中8例分类为2类。当评估单个NST参数时,观察到加速度存在的一致性非常强(0.84)。在NST分类(0.64),存在减速(0.79)和可变性存在(0.67)方面发现了良好的一致性。相比之下,在减速类型的分类(0.53)和变异性的分级(0.47)方面,只有中等程度的一致性(表1)。减速类型的详细比较显示弱至中度一致性(0.29)。“深度延长”减速被两位评估者一致认可,而在识别“复发性晚期”、“深度晚期”和“可变”模式时,发现了显著的差异。这些结果表明,虽然人工智能在一般模式识别中表现出可接受的性能,但其区分特定和复杂模式的能力仍然有限。结论本研究显示人工智能与临床评价有一定程度的一致性。对于减速类型和可变性等细微参数,该协议较低;但人工智能仍然可以支持早期诊断和基于证据的决策。影响声明本研究引入了一种基于人工智能的临床解释方法,如NST分类,旨在提高诊断清晰度和支持临床教育。
{"title":"Comparison of Clinical and Artificial Intelligence (AI)-Based Interpretation: Agreement and Diagnostic Consistency","authors":"Simge Berrak Beyoglu Oruc ,&nbsp;Rozerin Balci ,&nbsp;Berfin Baybas ,&nbsp;Busra Toper","doi":"10.1016/j.rbmo.2025.105302","DOIUrl":"10.1016/j.rbmo.2025.105302","url":null,"abstract":"<div><h3>OBJECTIVE</h3><div>Artificial intelligence (AI)-based models trained on large datasets and advanced algorithms employ signal processing and pattern recognition techniques to reduce subjectivity and human error in the evaluation of Non-Stress Tests (NST). This study examined the agreement between clinician and AI-based NST evaluations, highlighting AI’s potential in clinical decision support.</div></div><div><h3>MATERIALS AND METHODS</h3><div>In a cohort of 100 patients, NST parameters were assessed by both clinical interpretation and ChatGPT, categorized into seven subcomponents, and Inter-rater agreement was assessed using Cohen’s Kappa coefficient.</div></div><div><h3>RESULTS</h3><div>Good agreement was observed between clinician and ChatGPT evaluations (Kappa 0.655, accuracy 77%). Subgroup analyses showed moderate agreement in cases undergoing cesarean section due to fetal distress (Kappa 0.47, accuracy 76%), with ChatGPT classifying 87% of these cases as Category 3. Notably, no patients in this subgroup were classified as Category 1 by ChatGPT, suggesting a conservative approach in high-risk scenarios. In the non-reactive NST subgroup, moderate agreement (0.42) was also observed. In all 9 cases of fetal tachycardia, ChatGPT correctly identified the condition (100% accuracy) and classified 8 of them as Category 2.</div><div>When evaluating individual NST parameters, a very strong agreement was observed for the presence of accelerations (0.84). Good agreement was found in NST categorization (0.64), presence of decelerations (0.79),and variability presence (0.67). In contrast, only moderate agreement was observed in the classification of deceleration types (0.53) and grading of variability (0.47) (Table 1). Detailed comparison of deceleration type revealed weak-to-moderate agreement (0.29). “Deep prolonged” decelerations were consistently recognized by both evaluators, whereas significant discrepancies were noted in identifying “recurrent late,” “deep late,” and “variable” patterns. These results indicate that while AI shows acceptable performance in general pattern recognition, its ability to distinguish specific and complex patterns remains limited.</div></div><div><h3>CONCLUSIONS</h3><div>This study demonstrated moderate agreement between AI and clinical evaluations. The agreement was lower for nuanced parameters, such as deceleration type and variability; yet AI could still support early diagnosis and evidence-based decision-making.</div></div><div><h3>IMPACT STATEMENT</h3><div>This study introduces an AI-based approach for clinical interpreting, such as NST categorization, aiming to enhance diagnostic clarity and support clinical education.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"51 ","pages":"Article 105302"},"PeriodicalIF":3.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145532940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Tuba-ovarian Abscess After Incomplete Surgery and Drainage in an Endometrioma: A Case Report 子宫内膜异位瘤不完全手术引流后输卵管卵巢脓肿的处理:1例报告
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rbmo.2025.105332
Simge Berrak Beyoglu Oruc

OBJECTIVE

The weak cyst wall and the creation of a culture medium for hemorrhagic content may theoretically facilitate bacterial implantation and infection. We aimed to discuss the importance of preoperative evaluation in preventing incomplete surgeries in deep infiltrative endometriosis, the management of abscess after ovarian drilling.

MATERIALS AND METHODS

Case Report
A 31-year-old G0P0A0 nulliparous was admitted with high fever and pelvic pain. In the patient's history, it was learned that laparoscopic 4-centimeter(cm) right ovary endometrioma cyst excision, left ovary drilling and endometriotic noduls cauterization were performed at an external center 20 days ago. In her preoperative application, she reported pelvic pain and dysmenorrhea, and a gynecological evaluation revealed an 8-cm endometrioma cyst on a pelvic MRI. The patient had laparoscopic excision of a right ovarian endometrioma, left ovarian drilling, and cauterization of nodules, followed by a single dose of GnRH agonist for suppression therapy. The patient was hospitalized with the diagnosis of tubo-ovarian abscess with CRP: 223 mg/L and observation of a 5-cm heterogeneous collection area in the left adnexal area on the pelvic MRI.
After clinical and laboratory improvement with antibiotherapy, pelvic MRI showed a persistent 5-cm left adnexal mass (Figure 1). Preoperative AMH was 5.6 ng/mL and postoperative AMH 1.98 ng/mL, indicating a postoperative loss of ovarian reserve. Hysterosalpingography (HSG) showed normal right tubal passage and significant hydrosalpinx with no passage in the left tube.

RESULTS

Discussion
We believe that the use of ovarian drilling is an outdated approach, and that the abscess complication observed following incomplete surgery was attributable to this procedure. Considering the relatively lower negative impact of sterile hydrosalpinx, associated with endometrioma, on implantation success compared to septic hydrosalpinx secondary to pelvic inflammatory disease, the patient was offered an opportunity for spontaneous conception before planning secondary surgical intervention.

CONCLUSIONS

New treatment options, such as sclerotherapy, are also reported to have positive results in symptomatic improvement and pregnancy outcomes. Medical management was chosen, with follow-up for spontaneous conception due to the risk of diminished ovarian reserve from a second surgery.

IMPACT STATEMENT

Treatment options and complication management in surgical or medical treatments for deep infiltrative endometriosis need to be individualized.
目的薄弱的囊肿壁和为出血内容物创造的培养基理论上可能有利于细菌着床和感染。我们的目的是讨论术前评估在预防深度浸润性子宫内膜异位症手术不完全的重要性,以及卵巢钻孔后脓肿的处理。材料与方法病例报告一例31岁高龄产妇因高热及盆腔疼痛入院。病史中了解到,20天前于外中心行腹腔镜下4厘米(cm)右卵巢子宫内膜瘤囊肿切除、左卵巢钻孔及子宫内膜异位症结节烧灼术。在她的术前申请中,她报告盆腔疼痛和痛经,妇科检查显示盆腔MRI显示一个8厘米的子宫内膜瘤囊肿。患者在腹腔镜下切除右侧卵巢子宫内膜瘤,左侧卵巢钻孔,烧灼结节,随后给予单剂量GnRH激动剂进行抑制治疗。患者入院诊断为输卵管卵巢脓肿,CRP: 223 mg/L,盆腔MRI观察左侧附件区5 cm异质收集区。经临床和实验室抗生素治疗改善后,骨盆MRI显示持续5厘米的左侧附件肿块(图1)。术前AMH为5.6 ng/mL,术后AMH为1.98 ng/mL,提示卵巢储备功能丧失。子宫输卵管造影(HSG)显示右侧输卵管通道正常,左侧输卵管无通道,明显输卵管积液。结果讨论我们认为使用卵巢钻孔是一种过时的方法,不完全手术后观察到的脓肿并发症可归因于这种方法。考虑到与盆腔炎继发的脓毒性输卵管积水相比,子宫内膜异位瘤相关的无菌输卵管积水对植入成功的负面影响相对较小,因此在计划继发手术干预之前,为患者提供了一个自然受孕的机会。新的治疗方案,如硬化疗法,也被报道在症状改善和妊娠结局方面有积极的结果。选择医疗管理,由于第二次手术卵巢储备减少的风险,对自然受孕进行随访。影响声明深浸润性子宫内膜异位症的手术或药物治疗方案和并发症管理需要个体化。
{"title":"Management of Tuba-ovarian Abscess After Incomplete Surgery and Drainage in an Endometrioma: A Case Report","authors":"Simge Berrak Beyoglu Oruc","doi":"10.1016/j.rbmo.2025.105332","DOIUrl":"10.1016/j.rbmo.2025.105332","url":null,"abstract":"<div><h3>OBJECTIVE</h3><div>The weak cyst wall and the creation of a culture medium for hemorrhagic content may theoretically facilitate bacterial implantation and infection. We aimed to discuss the importance of preoperative evaluation in preventing incomplete surgeries in deep infiltrative endometriosis, the management of abscess after ovarian drilling.</div></div><div><h3>MATERIALS AND METHODS</h3><div>Case Report</div><div>A 31-year-old G0P0A0 nulliparous was admitted with high fever and pelvic pain. In the patient's history, it was learned that laparoscopic 4-centimeter(cm) right ovary endometrioma cyst excision, left ovary drilling and endometriotic noduls cauterization were performed at an external center 20 days ago. In her preoperative application, she reported pelvic pain and dysmenorrhea, and a gynecological evaluation revealed an 8-cm endometrioma cyst on a pelvic MRI. The patient had laparoscopic excision of a right ovarian endometrioma, left ovarian drilling, and cauterization of nodules, followed by a single dose of GnRH agonist for suppression therapy. The patient was hospitalized with the diagnosis of tubo-ovarian abscess with CRP: 223 mg/L and observation of a 5-cm heterogeneous collection area in the left adnexal area on the pelvic MRI.</div><div>After clinical and laboratory improvement with antibiotherapy, pelvic MRI showed a persistent 5-cm left adnexal mass (Figure 1). Preoperative AMH was 5.6 ng/mL and postoperative AMH 1.98 ng/mL, indicating a postoperative loss of ovarian reserve. Hysterosalpingography (HSG) showed normal right tubal passage and significant hydrosalpinx with no passage in the left tube.</div></div><div><h3>RESULTS</h3><div>Discussion</div><div>We believe that the use of ovarian drilling is an outdated approach, and that the abscess complication observed following incomplete surgery was attributable to this procedure. Considering the relatively lower negative impact of sterile hydrosalpinx, associated with endometrioma, on implantation success compared to septic hydrosalpinx secondary to pelvic inflammatory disease, the patient was offered an opportunity for spontaneous conception before planning secondary surgical intervention.</div></div><div><h3>CONCLUSIONS</h3><div>New treatment options, such as sclerotherapy, are also reported to have positive results in symptomatic improvement and pregnancy outcomes. Medical management was chosen, with follow-up for spontaneous conception due to the risk of diminished ovarian reserve from a second surgery.</div></div><div><h3>IMPACT STATEMENT</h3><div>Treatment options and complication management in surgical or medical treatments for deep infiltrative endometriosis need to be individualized.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"51 ","pages":"Article 105332"},"PeriodicalIF":3.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145532479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Reproductive biomedicine online
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1